Korsana Biosciences (KRSA) EBIT Margin (2019 - 2025)
Korsana Biosciences (KRSA) recorded EBIT Margin of -114.97% in Q3 2025, up 466.47 percentage points from -581.44% a year earlier and up 1682.88 percentage points from the prior quarter.
Powered by 
Analysis
Korsana Biosciences (KRSA) EBIT Margin (2019 - 2025) Analysis & Trends
On a TTM basis, Korsana Biosciences' EBIT Margin came in at -127.25% as of Sep 30, 2025, up 2926.87 percentage points year-over-year; for FY2024, it was -181.40%.
- Annual EBIT Margin has a five-year change of +2592.88 percentage points (FY2019 to FY2024).
- Across earlier years, EBIT Margin came in at -6242.42% in FY2022 (-4842.25 pp), -1400.18% in FY2021 (+2139.24 pp) and -3539.42% in FY2020 (-765.13 pp).
- Quarterly EBIT Margin has ranged from -21604.84% in Q1 2021 to 27.80% in Q4 2024 over the past five years.
- Peak year-over-year performance for EBIT Margin in the last five years was a gain of 19778.68 percentage points in Q1 2022, against a drop of 19574.37 percentage points in Q1 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at -1797.85% (Q2 2025), -1798.77% (Q1 2025) and 27.80% (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Korsana Biosciences | 16.27 Mn | 1.82 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -114.97% |
| Jun 30, 2025 | -1,797.85% |
| Mar 31, 2025 | -1,798.77% |
| Dec 31, 2024 | 27.80% |
| Sep 30, 2024 | -581.44% |
| Jun 30, 2022 | -4,389.87% |
| Mar 31, 2022 | -1,826.16% |
| Dec 31, 2021 | -2,690.06% |
| Sep 30, 2021 | -3,242.82% |
| Jun 30, 2021 | -539.20% |
| Mar 31, 2021 | -21,604.84% |
| Dec 31, 2020 | -14,454.14% |
| Sep 30, 2020 | -5,445.00% |
| Jun 30, 2020 | -2,626.44% |
| Mar 31, 2020 | -2,030.47% |
| Dec 31, 2019 | -1,795.14% |
| Sep 30, 2019 | -2,004.01% |
| Jun 30, 2019 | -2,030.34% |
API Access
Korsana Biosciences EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=KRSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "KRSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=KRSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();